Rodman & Renshaw acted as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNPR:
- Monopar Therapeutics announces common stock offering, no amount given
- Monopar Therapeutics Secures License for Wilson Disease Treatment
- Monopar Therapeutics enters agreement with Alexion, AstraZeneca Rare Disease
- Monopar Therapeutics Unveils Promising Radiopharmaceutical Data
- Monopar Therapeutics presents data from radiopharma program based on MNPR-101